Transaction by Persons Closely Associated to PDMRs
15/05/2025 07:00
RNS Number : 7261I
Diaceutics PLC
15 May 2025
Notification of Transaction by Persons Closely Associated ("PCAs") to Persons Discharging Managerial Responsibilities ("PDMRs")
New York, Belfast and London, 15 May 2025 - Diaceutics PLC (AIM: DXRX), a leading technology and solutions provider to the pharma and biotech industry, announces that it has been notified that on 13 May 2025, Delia Keeling, a person closely associated with Peter Keeling, Chair of Diaceutics, and spouse of Peter Keeling, sold 500,000 ordinary shares of £0.002 each in the Company ("Ordinary Shares") at a price of 126 pence per Ordinary Share. As a result of the sale, Peter and Delia Keeling's combined shareholding in Diaceutics is 15,252,049 Ordinary Shares representing approximately 17.98% of the Company's issued share capital.
This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR. The person responsible for making this announcement on behalf of the Company is Nick Roberts, Chief Financial Officer.
Enquiries:
|
| Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014 | |||||||
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||||||
| a. | Name | Delia Keeling | |||||
| 2 | Reason for notification | ||||||
| a. | Position/Status | PCA to Peter Keeling, Chair | |||||
| b. | Initial notification/ Amendment | Initial | |||||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||||
| a. | Name | Diaceutics PLC | |||||
| b. | LEI | 213800VEWQBB39ZB8J81 | |||||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||
| a. | Description of the financial instrument, type of instrument Identification Code | Ordinary shares of £0.002 each ISIN: GB00BJQTGV64 | |||||
| b. | Nature of the transaction | Sale | |||||
| c. | Price(s) and volume(s) | ||||||
| Price(s) | Volume(s) | ||||||
| £1.26 | 500,000 | ||||||
| d. | Date of the transaction | 13 May 2025 | |||||
| e. | Place of the transaction | AIM Market of the London Stock Exchange | |||||
| NOTIFICATION OF MAJOR HOLDINGS | ||||||
| 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii: | Diaceutics PLC ORD GBP0.002 | |||||
| 1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate) | ||||||
| Non-UK issuer | ||||||
| 2. Reason for the notification(please mark the appropriate box or boxes with an "X") | ||||||
| An acquisition or disposal of voting rights | X | |||||
| An acquisition or disposal of financial instruments | ||||||
| An event changing the breakdown of voting rights | ||||||
| Other (please specify) iii: | ||||||
| 3. Details of person subject to the notification obligationiv | ||||||
| Name | Peter & Delia Keeling | |||||
| City and country of registered office (if applicable) | NA | |||||
| 4. Full name of shareholder(s)(if different from 3.)v | ||||||
| Name | ||||||
| City and country of registered office (if applicable) | ||||||
| 5. Date on which the threshold was crossed or reachedvi: | 13 May, 2025 | |||||
| 6. Date on which issuer notified: | 13 May, 2025 | |||||
| 7. Total positions of person(s) subject to the notification obligation | ||||||
| % of voting rights attached to shares (total of 8. A) | % of voting rights through financial instruments (total of 8.B 1 + 8.B 2) | Total of both in % (8.A + 8.B) | Total number of voting rights held in issuer (8.A + 8.B)vii | |||
| Resulting situation on the date on which threshold was crossed or reached | 17.98% | 17.98% | ||||
| Position of previous notification (if applicable) | 18.60% | 18.60% | ||||
| 8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii | |||||||||
| A: Voting rights attached to shares | |||||||||
| Class/type of shares ISIN code (if possible) | Number of voting rightsix | % of voting rights | |||||||
| Direct (DTR5.1) | Indirect (DTR5.2.1) | Direct (DTR5.1) | Indirect (DTR5.2.1) | ||||||
| GB00BJQTGV64 | 15,252,049 | 17.98% | |||||||
| SUBTOTAL 8. A | 15,252,049 | ||||||||
| B 1: Financial Instruments according to DTR5.3.1R (1) (a) | |||||||||
| Type of financial instrument | Expiration datex | Exercise/ Conversion Periodxi | Number of voting rights that may be acquired if the instrument is exercised/converted. | % of voting rights | |||||
| SUBTOTAL 8. B 1 | |||||||||
| B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b) | |||||||||
| Type of financial instrument | Expiration datex | Exercise/ Conversion Periodxi | Physical or cash Settlementxii | Number of voting rights | % of voting rights | ||||
| SUBTOTAL 8.B.2 | |||||||||
| 9. Information in relation to the person subject to the notification obligation(please mark the applicable box with an "X") | ||||
| Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii | ||||
| Fullchain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary)xiv | ||||
| Namexv | % of voting rights if it equals or is higher than the notifiable threshold | % of voting rights through financial instruments if it equals or is higher than the notifiable threshold | Total of both if it equals or is higher than the notifiable threshold | |
| 10. In case of proxy voting, please identify: | ||||
| Name of the proxy holder | ||||
| The number and % of voting rights held | ||||
| The date until which the voting rights will be held | ||||
| 11. Additional informationxvi | ||||
| Place of completion | AIM Stock Exchange, London |
| Date of completion | 13 May, 2025 |